Melflufen Demonstrates Efficacy in LIGHTHOUSE Trial; Drug's Future Still Unclear
Melflufen plus daratumumab and dexamethasone produced better outcomes than daratumumab alone in relapsed/refractory multiple myeloma.
Stay updated with breaking news from Published August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Melflufen plus daratumumab and dexamethasone produced better outcomes than daratumumab alone in relapsed/refractory multiple myeloma.
Enter the realm of magic with "Witches Tome," Habanero's latest slot sensation. Discover replicated Wilds, spooky Scatters, and the locked re-spins feature for captivating gameplay. Unveil mystical rewards and win over 7000x your initial bet!
Bloodbath at PSX as jittery investors jettison shares over ‘weakening rupee, economic uncertainty’ Talqeen Zubairi Published August 31, 2023 Updated 3...
Who is Zakariya Kamal Sufi Abashiekh? What does he do? What is his relationship with China (if any) and has the Chinese embassy responded?
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.